{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:23:22Z","timestamp":1759623802606,"version":"build-2065373602"},"reference-count":34,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2025,9,30]]},"DOI":"10.1536\/ihj.25-273","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T22:09:02Z","timestamp":1759183742000},"page":"786-793","source":"Crossref","is-referenced-by-count":1,"title":["Association Between Improvement in Left Ventricular Ejection Fraction and Prognosis of Patients with Cardiac Sarcoidosis"],"prefix":"10.1536","volume":"66","author":[{"given":"Daichi","family":"Maeda","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Matsue","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yudai","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taishi","family":"Dotare","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsutomu","family":"Sunayama","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Yoshioka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Kameda Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeru","family":"Nabeta","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Kitasato University School of Medicine"},{"name":"Department of Cardiology, Leiden University Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Naruse","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Internal Medicine III, Hamamatsu University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Kitai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsunori","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekazu","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Morimoto","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Nagoya University Graduate School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuichi","family":"Baba","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Geriatrics, Kochi Medical School, Kochi University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tohru","family":"Minamino","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine"},{"name":"Japan Agency for Medical Research and Development-Core Research for Evolutionary Medical Science and Technology (AMED-CREST), Japan Agency for Medical Research and Development"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"doi-asserted-by":"crossref","unstructured":"1. Drent M, Crouser ED, Grunewald J. Challenges of Sarcoidosis and Its Management. N Engl J Med 2021; 385: 1018-32.","key":"1","DOI":"10.1056\/NEJMra2101555"},{"doi-asserted-by":"crossref","unstructured":"2. Yakhshimurodov U, Yamashita K, Kawamura T, <i>et al<\/i>. Paradigm shift in myocarditis treatment. J Cardiol 2024; 83: 201-10.","key":"2","DOI":"10.1016\/j.jjcc.2023.08.009"},{"doi-asserted-by":"crossref","unstructured":"3. Grunewald J, Grutters JC, Arkema EV, <i>et al<\/i>. Sarcoidosis. Nat Rev Dis Primers 2019; 5: 45.","key":"3","DOI":"10.1038\/s41572-019-0096-x"},{"doi-asserted-by":"crossref","unstructured":"4. Birnie DH, Kandolin R, Nery PB, <i>et al<\/i>. Cardiac manifestations of sarcoidosis: diagnosis and management. Eur Heart J 2017; 38: 2663-70.","key":"4","DOI":"10.1093\/eurheartj\/ehw328"},{"doi-asserted-by":"crossref","unstructured":"5. Hagiwara H, Watanabe M, Kadosaka T, <i>et al<\/i>. Fragmented QRS on 12-lead electrocardiogram predicts long-term prognosis in patients with cardiac sarcoidosis. Heart Vessels 2023; 38: 803-16.","key":"5","DOI":"10.1007\/s00380-022-02229-2"},{"doi-asserted-by":"publisher","unstructured":"6. Kusano K, Ishibashi K, Noda T, <i>et al<\/i>. Prognosis and Outcomes of Clinically Diagnosed Cardiac Sarcoidosis Without Positive Endomyocardial Biopsy Findings. JACC Asia 2021; 1: 385-95.","key":"6","DOI":"10.1016\/j.jacasi.2021.09.005"},{"doi-asserted-by":"crossref","unstructured":"7. Cacoub P, Chapelon-Abric C, Resche-Rigon M, <i>et al<\/i>. Cardiac sarcoidosis: A long term follow up study. PLoS One 2020; 15: e0238391.","key":"7","DOI":"10.1371\/journal.pone.0238391"},{"doi-asserted-by":"publisher","unstructured":"8. Nordenswan HK, Poyhonen P, Lehtonen J, <i>et al<\/i>. Incidence of Sudden Cardiac Death and Life-Threatening Arrhythmias in Clinically Manifest Cardiac Sarcoidosis With and Without Current Indications for an Implantable Cardioverter Defibrillator. Circulation 2022; 146: 964-75.","key":"8","DOI":"10.1161\/CIRCULATIONAHA.121.058120"},{"doi-asserted-by":"crossref","unstructured":"9. Nabeta T, Kitai T, Naruse Y, <i>et al<\/i>. Risk stratification of patients with cardiac sarcoidosis: the ILLUMINATE-CS registry. Eur Heart J 2022; 43: 3450-9.","key":"9","DOI":"10.1093\/eurheartj\/ehac323"},{"key":"10","first-page":"1305","volume":"11","year":"2014","unstructured":"10. Birnie DH, Sauer WH, Bogun F, <i>et al<\/i>. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 2014; 11: 1305-23.","journal-title":"Heart Rhythm","ISSN":"https:\/\/id.crossref.org\/issn\/1547-5271","issn-type":"print"},{"doi-asserted-by":"crossref","unstructured":"11. Terasaki F, Azuma A, Anzai T, <i>et al<\/i>. JCS 2016 Guideline on Diagnosis and Treatment of Cardiac Sarcoidosis - Digest Version. Circ J 2019; 83: 2329-88.","key":"11","DOI":"10.1253\/circj.CJ-19-0508"},{"doi-asserted-by":"publisher","unstructured":"12. Kandolin R, Lehtonen J, Airaksinen J, <i>et al<\/i>. Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study. Circulation 2015; 131: 624-32.","key":"12","DOI":"10.1161\/CIRCULATIONAHA.114.011522"},{"key":"13","doi-asserted-by":"crossref","first-page":"euad273","DOI":"10.1093\/europace\/euad273","volume":"25","year":"2023","unstructured":"13. Hutt E, Brizneda MV, Goldar G, <i>et al<\/i>. Optimal left ventricular ejection fraction in risk stratification of patients with cardiac sarcoidosis. Europace 2023; 25: euad273.","journal-title":"Europace","ISSN":"https:\/\/id.crossref.org\/issn\/1099-5129","issn-type":"print"},{"doi-asserted-by":"crossref","unstructured":"14. Padala SK, Peaslee S, Sidhu MS, <i>et al<\/i>. Impact of early initiation of corticosteroid therapy on cardiac function and rhythm in patients with cardiac sarcoidosis. Int J Cardiol 2017; 227: 565-70.","key":"14","DOI":"10.1016\/j.ijcard.2016.10.101"},{"doi-asserted-by":"crossref","unstructured":"15. Nagai T, Nagano N, Sugano Y, <i>et al<\/i>. Effect of Corticosteroid Therapy on Long-Term Clinical Outcome and Left Ventricular Function in Patients With Cardiac Sarcoidosis. Circ J 2015; 79: 1593-600.","key":"15","DOI":"10.1253\/circj.CJ-14-1275"},{"doi-asserted-by":"crossref","unstructured":"16. Kramer DG, Trikalinos TA, Kent DM, <i>et al<\/i>. Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach. J Am Coll Cardiol 2010; 56: 392-406.","key":"16","DOI":"10.1016\/j.jacc.2010.05.011"},{"doi-asserted-by":"crossref","unstructured":"17. Si J, Ding Z, Hu Y, <i>et al<\/i>. Predictors and prognostic implications of left ventricular ejection fraction trajectory improvement in the spectrum of heart failure with reduced and mildly reduced ejection fraction. J Cardiol 2024; 83: 250-7.","key":"17","DOI":"10.1016\/j.jjcc.2023.09.012"},{"doi-asserted-by":"crossref","unstructured":"18. Nishihara Y, Nishimori M, Sawa T, <i>et al<\/i>. Left ventricular reverse remodeling following initiation of sacubitril\/valsartan for heart failure with reduced ejection fraction and low blood pressure. Heart Vessels 2024; 39: 95-104.","key":"18","DOI":"10.1007\/s00380-023-02311-3"},{"doi-asserted-by":"publisher","unstructured":"19. Sohn DW, Park JB. Cardiac sarcoidosis. Heart 2023; 109: 1132-8.","key":"19","DOI":"10.1136\/heartjnl-2022-321379"},{"doi-asserted-by":"crossref","unstructured":"20. Maeda D, Matsue Y, Dotare T, <i>et al<\/i>. Clinical characteristics and prognosis of patients with isolated cardiac sarcoidosis: Insights from the ILLUMINATE-CS study. Eur J Heart Fail 2024; 26: 77-86.","key":"20","DOI":"10.1002\/ejhf.3056"},{"doi-asserted-by":"publisher","unstructured":"21. Iso T, Maeda D, Matsue Y, <i>et al<\/i>. Sex differences in clinical characteristics and prognosis of patients with cardiac sarcoidosis. Heart 2023; 109: 1387-93. 20230824.","key":"21","DOI":"10.1136\/heartjnl-2022-322243"},{"doi-asserted-by":"crossref","unstructured":"22. Zeppenfeld K, Tfelt-Hansen J, de Riva M, <i>et al<\/i>. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 2022; 43: 3997-4126.","key":"22","DOI":"10.1093\/eurheartj\/ehac699"},{"doi-asserted-by":"crossref","unstructured":"23. Chiu CZ, Nakatani S, Zhang G, <i>et al<\/i>. Prevention of left ventricular remodeling by long-term corticosteroid therapy in patients with cardiac sarcoidosis. Am J Cardiol 2005; 95: 143-6.","key":"23","DOI":"10.1016\/j.amjcard.2004.08.083"},{"doi-asserted-by":"crossref","unstructured":"24. Wand AL, Pavlovic N, Duvall C, <i>et al<\/i>. Effect of Corticosteroids on Left Ventricular Function in Patients With Cardiac Sarcoidosis. Am J Cardiol 2022; 177: 108-15.","key":"24","DOI":"10.1016\/j.amjcard.2022.04.051"},{"doi-asserted-by":"crossref","unstructured":"25. Lehtonen J, Uusitalo V, Poyhonen P, <i>et al<\/i>. Cardiac sarcoidosis: phenotypes, diagnosis, treatment, and prognosis. Eur Heart J 2023; 44: 1495-510.","key":"25","DOI":"10.1093\/eurheartj\/ehad067"},{"doi-asserted-by":"crossref","unstructured":"26. Straw S, McGinlay M, Gierula J, <i>et al<\/i>. Impact of QRS duration on left ventricular remodelling and survival in patients with heart failure. J Cardiovasc Med (Hagerstown) 2021; 22: 848-56.","key":"26","DOI":"10.2459\/JCM.0000000000001231"},{"doi-asserted-by":"crossref","unstructured":"27. Choi JO, Kim EY, Lee GY, <i>et al<\/i>. Predictors of left ventricular reverse remodeling and subsequent outcome in nonischemic dilated cardiomyopathy. Circ J 2013; 77: 462-9.","key":"27","DOI":"10.1253\/circj.CJ-12-0507"},{"doi-asserted-by":"crossref","unstructured":"28. Kashani A, Barold SS. Significance of QRS complex duration in patients with heart failure. J Am Coll Cardiol 2005; 46: 2183-92.","key":"28","DOI":"10.1016\/j.jacc.2005.01.071"},{"doi-asserted-by":"crossref","unstructured":"29. Kalogeropoulos AP, Fonarow GC, Georgiopoulou V, <i>et al<\/i>. Characteristics and Outcomes of Adult Outpatients With Heart Failure and Improved or Recovered Ejection Fraction. JAMA Cardiol 2016; 1: 510-8.","key":"29","DOI":"10.1001\/jamacardio.2016.1325"},{"doi-asserted-by":"crossref","unstructured":"30. Lupon J, Diez-Lopez C, de Antonio M, <i>et al<\/i>. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study. Eur J Heart Fail 2017; 19: 1615-23.","key":"30","DOI":"10.1002\/ejhf.824"},{"doi-asserted-by":"crossref","unstructured":"31. DeVore AD, Hellkamp AS, Thomas L, <i>et al<\/i>. The association of improvement in left ventricular ejection fraction with outcomes in patients with heart failure with reduced ejection fraction: data from CHAMP-HF. Eur J Heart Fail 2022; 24: 762-70.","key":"31","DOI":"10.1002\/ejhf.2486"},{"doi-asserted-by":"publisher","unstructured":"32. Sairaku A, Yoshida Y, Nakano Y, <i>et al<\/i>. Cardiac resynchronization therapy for patients with cardiac sarcoidosis. Europace 2017; 19: 824-30.","key":"32","DOI":"10.1093\/europace\/euw223"},{"doi-asserted-by":"crossref","unstructured":"33. Skowasch D, Ringquist S, Nickenig G, <i>et al<\/i>. Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator. PLoS One 2018; 13: e0194496.","key":"33","DOI":"10.1371\/journal.pone.0194496"},{"doi-asserted-by":"publisher","unstructured":"34. Kitai T, Nabeta T, Naruse Y, <i>et al<\/i>. Comparisons between biopsy-proven versus clinically diagnosed cardiac sarcoidosis. Heart 2022; 108: 1887-94.","key":"34","DOI":"10.1136\/heartjnl-2022-320932"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/66\/5\/66_25-273\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T03:53:58Z","timestamp":1759550038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/66\/5\/66_25-273\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,30]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.25-273","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"type":"print","value":"1349-2365"},{"type":"electronic","value":"1349-3299"}],"subject":[],"published":{"date-parts":[[2025,9,30]]},"article-number":"25-273"}}